Get the Stockscreener App
23.39
1.85%
-0.44
After Hours:
23.39
Tg Therapeutics Inc stock is traded at $23.39, with a volume of 2.17M.
It is down -1.85% in the last 24 hours and down -0.43% over the past month.
See More
Previous Close:
$23.83
Open:
$23.74
24h Volume:
2.17M
Relative Volume:
0.64
Market Cap:
$3.60B
Revenue:
$346.73M
Net Income/Loss:
$95.69M
P/E Ratio:
-83.54
EPS:
-0.28
Net Cash Flow:
$67.82M
1W Performance:
+0.60%
1M Performance:
-0.43%
6M Performance:
+53.78%
1Y Performance:
+179.78%
1-Day Range:
$23.32
$24.40
1-Week Range:
$22.68
$24.40
52-Week Range:
$6.46
$26.41
Tg Therapeutics Inc Stock (TGTX) Company Profile
Name
Tg Therapeutics Inc
Sector
Industry
Phone
(212) 554-4484
Address
2 GANSEVOORT STREET, 9TH FLOOR, NEW YORK, NY
Tg Therapeutics Inc Stock (TGTX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-02-23 | Upgrade | Goldman | Sell → Neutral |
| Jun-26-23 | Resumed | Jefferies | Buy |
| May-20-22 | Initiated | BofA Securities | Underperform |
| Feb-23-22 | Reiterated | B. Riley Securities | Buy |
| Nov-15-21 | Downgrade | Goldman | Neutral → Sell |
| Apr-20-21 | Initiated | Goldman | Neutral |
| Apr-19-21 | Reiterated | H.C. Wainwright | Buy |
| Sep-01-20 | Initiated | JP Morgan | Overweight |
| Aug-11-20 | Reiterated | H.C. Wainwright | Buy |
| Jun-05-20 | Initiated | Evercore ISI | Outperform |
| Jan-17-20 | Reiterated | H.C. Wainwright | Buy |
| Nov-27-19 | Resumed | B. Riley FBR | Buy |
| Feb-06-19 | Resumed | Jefferies | Buy |
| Sep-25-18 | Downgrade | Raymond James | Strong Buy → Outperform |
| Mar-09-18 | Reiterated | B. Riley FBR, Inc. | Buy |
| Dec-01-17 | Resumed | B. Riley FBR, Inc. | Buy |
| Nov-14-17 | Resumed | H.C. Wainwright | Buy |
| Apr-25-17 | Initiated | Jefferies | Buy |
| Mar-06-17 | Reiterated | FBR & Co. | Outperform |
| Oct-06-16 | Resumed | Brean Capital | Buy |
| May-27-16 | Initiated | SunTrust | Buy |
| Dec-01-15 | Initiated | FBR Capital | Outperform |
| Sep-09-15 | Initiated | Raymond James | Strong Buy |
| Aug-12-15 | Resumed | H.C. Wainwright | Buy |
| Jun-19-15 | Reiterated | Brean Capital | Buy |
| Dec-11-14 | Reiterated | ROTH Capital | Buy |
| Dec-10-14 | Reiterated | ROTH Capital | Buy |
View All
Tg Therapeutics Inc Stock (TGTX) Latest News
TG Therapeutics, Inc.'s (NASDAQ:TGTX) institutional investors lost 3.3% over the past week but have profited from longer-term gains - Simply Wall St
111,092 Shares in TG Therapeutics, Inc. (NASDAQ:TGTX) Acquired by Lighthouse Investment Partners LLC - MarketBeat
Dark Forest Capital Management LP Acquires New Holdings in TG Therapeutics, Inc. (NASDAQ:TGTX) - MarketBeat
Marshall Wace LLP Buys New Position in TG Therapeutics, Inc. (NASDAQ:TGTX) - MarketBeat
Point72 Europe London LLP Takes Position in TG Therapeutics, Inc. (NASDAQ:TGTX) - MarketBeat
Profund Advisors LLC Reduces Stock Holdings in TG Therapeutics, Inc. (NASDAQ:TGTX) - MarketBeat
Hood River Capital Management LLC Buys 98,892 Shares of TG Therapeutics, Inc. (NASDAQ:TGTX) - MarketBeat
How to Take Advantage of moves in (TGTX) - Stock Traders Daily
TG Therapeutics: A Look At New Briumvi Data And Ocrevus Zunovo Approval (NASDAQ:TGTX) - Seeking Alpha
State of New Jersey Common Pension Fund D Purchases Shares of 113,683 TG Therapeutics, Inc. (NASDAQ:TGTX) - MarketBeat
TG Therapeutics Inc (TGTX): Short Seller Sentiment is Bearish - Insider Monkey
TG Therapeutics Inc (TGTX): Short Seller Sentiment is Bearish - Yahoo Finance
14 Worst 52-Week High Stocks to Buy According to Short Sellers - Insider Monkey
TG Therapeutics (NASDAQ:TGTX) Shares Down 5.4% - MarketBeat
IBD 50's TG Therapeutics Rises On Five-Year Data For Multiple Sclerosis Drug - MSN
Are Robust Financials Driving The Recent Rally In TG Therapeutics, Inc.'s (NASDAQ:TGTX) Stock? - Yahoo Finance
Strong new data for Briumvi in MS - The Pharma Letter
TG Therapeutics shares update on BRIUMVI infusion study By Investing.com - Investing.com South Africa
TG Therapeutics' (TGTX) "Buy" Rating Reiterated at HC Wainwright - MarketBeat
Evaluating TG Therapeutics: Insights From 4 Financial Analysts - Benzinga
IBD 50 Biotech Stock Rises On Five-Year Data For MS Drug - Investor's Business Daily
TGTXTG Therapeutics, Inc. Latest Stock News & Market Updates - StockTitan
TG Therapeutics’ (TGTX) “Buy” Rating Reiterated at HC Wainwright - Defense World
TG Therapeutics shares update on BRIUMVI infusion study By Investing.com - Investing.com Australia
What's Going On With TG Therapeutics Stock Wednesday? - Benzinga
TG Therapeutics shares update on BRIUMVI infusion study - Investing.com
TG Therapeutics shares update on BRIUMVI infusion study By Investing.com - Investing.com Canada
TG Therapeutics shares update on BRIUMVI infusion study By Investing.com - Investing.com UK
New BRIUMVI® (ublituximab-xiiy) Data from the ENHANCE Phase 3b Study Show Rapid 30-Minute Infusions are Well Tolerated in Patients with Relapsing Forms of Multiple Sclerosis - StockTitan
New Data for BRIUMVI® (ublituximab-xiiy) Demonstrate that 92% of Patients with Relapsing Multiple Sclerosis Were Free from Disability Progression After 5 Years of Treatment - StockTitan
TG Therapeutics (NASDAQ:TGTX) Hits New 52-Week High at $26.03 - MarketBeat
TG Therapeutics stock soars to 52-week high of $25.71 By Investing.com - Investing.com Australia
Sofinnova Investments Inc. Cuts Holdings in TG Therapeutics, Inc. (NASDAQ:TGTX) - MarketBeat
Ashton Thomas Private Wealth LLC Takes Position in TG Therapeutics, Inc. (NASDAQ:TGTX) - Defense World
TG Therapeutics stock soars to 52-week high of $25.71 By Investing.com - Investing.com Canada
TG Therapeutics (NASDAQ:TGTX) Trading 5.2% Higher - MarketBeat
TG Therapeutics stock soars to 52-week high of $25.71 - Investing.com
TG Therapeutics stock soars to 52-week high of $25.71 - Investing.com India
TG Therapeutics stock soars to 52-week high of $25.71 By Investing.com - Investing.com South Africa
TG Therapeutics stock soars to 52-week high of $25.71 By Investing.com - Investing.com UK
Interesting TGTX Put And Call Options For November 1st - Nasdaq
(TGTX) Technical Data - Stock Traders Daily
Bank of New York Mellon Corp Raises Holdings in TG Therapeutics, Inc. (NASDAQ:TGTX) - MarketBeat
Brokerages Set TG Therapeutics, Inc. (NASDAQ:TGTX) Price Target at $31.83 - MarketBeat
Strategic Financial Concepts LLC Takes Position in TG Therapeutics, Inc. (NASDAQ:TGTX) - MarketBeat
TG Therapeutics (NASDAQ:TGTX) Shares Gap Up to $22.03 - MarketBeat
TG Therapeutics And 7 Other Stocks Have High Sales Growth And An Above 3% Return on Equity - Via News Agency
TG Therapeutics Announces Schedule of Data Presentations - GlobeNewswire
TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI at the 2024 European Committee for Treatment and Research in Multiple Sclerosis Annual Meeting - StockTitan
TG Therapeutics stock soars to 52-week high of $25.44 By Investing.com - Investing.com Canada
TG Therapeutics (NASDAQ:TGTX) Sets New 12-Month High at $25.38 - MarketBeat
Tg Therapeutics Inc Stock (TGTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.05%
4.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):